Estimated average absolute and relative changes from the no-policy counterfactual by phase and food group. by Lindsey Smith Taillie (3159258)

Subjects:

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Neutrophil Superoxide anion production, Heat map for gene expression from neutrophils of CGD patients, and PCA plot for genome-wide gene expression. by Daniel R. Ambruso (12042605)

“…Heat map</b> showing changes for all significant genes between off IFN-γ and 10-12 hours after the 1st and 4th dose (50 µg/m²) of the cytokine given on a routine schedule noted in Methods. …”

Moran’s <i>I</i> of China’s educational development from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Results of <i>LM</i> test, <i>LR</i> test, <i>Wald</i> test and <i>Hausman</i> test. by Yuanzhi Guo (16624797)

Subjects:

Provincial educational development level in China from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Estimation results of spatial Durbin panel data model by regions. by Yuanzhi Guo (16624797)

Subjects:

Pre-selection of factors influencing the level of regional educational development. by Yuanzhi Guo (16624797)

Subjects:

Estimation results of spatial Durbin panel data model. by Yuanzhi Guo (16624797)

Subjects:

The evolution of China’s educational development from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Decomposition of the regional disparity in China’s educational development from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Regional inequality in China’s educational development from 2003 to 2020. by Yuanzhi Guo (16624797)

Subjects:

Changes in blood pressure, HbA1c, blood lipid and liver function-related indicator values compared with baseline values in all patients over time. by Jia Song (495396)

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

General procedure for the synthesis of B. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

The trends of gene expression in the metabolism of triglycerides in liver tissue. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”

The trends of cholesterol metabolism-related gene expression in liver tissue. by Xueqin lu (22250795)

Subjects: “…attenuates fibrosis progression…”